Nicky Thomas

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 8

Top Venues

ACS infectious diseases

Antimicrobial agents and chemotherapy

Molecular pharmaceutics

Drug delivery and translational research

University of South Australia

University of Otago (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Australia Jan 01 2016

Australia

NHMRC Early Career Researcher Fellow :: School of Pharmacy and Medical Sciences

University of South Australia

Australia

Research Associate :: Ian Wark Research Institute

University of Copenhagen Biotech Research and Innovation Centre

Denmark

Research Assistant :: Department of Pharmacy

Education History

University of Otago

New Zealand

PHD :: School of Pharmacy

Publications

Chelsea R Thorn, Anthony Wignall, Zlatko Kopecki, Anita Kral, Clive A Prestidge, Nicky Thomas
Liquid Crystal Nanoparticles Enhance Tobramycin Efficacy in a Murine Model of Pseudomonas aeruginosa Biofilm Wound Infection. ACS infectious diseases 8 (4) (2022)
Chelsea R Thorn, Cristiane de Souza Carvalho-Wodarz, Justus C Horstmann, Claus-Michael Lehr, Clive A Prestidge, Nicky Thomas
Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms. Small (Weinheim an der Bergstrasse, Germany) 17 (24) (2021)
Chelsea R Thorn, Nicky Thomas, Ben J Boyd, Clive A Prestidge
Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy. Drug delivery and translational research 11 (4) (2021)
Chelsea R Thorn, Deepa Raju, Ira Lacdao, Stephanie Gilbert, Piyanka Sivarajah, P Lynne Howell, Clive A Prestidge, Nicky Thomas
Protective Liquid Crystal Nanoparticles for Targeted Delivery of PslG: A Biofilm Dispersing Enzyme. ACS infectious diseases 7 (8) (2021)
Sajedeh Maghrebi, Paul Joyce, Manasi Jambhrunkar, Nicky Thomas, Clive A Prestidge
Poly(lactic-co-glycolic) Acid-Lipid Hybrid Microparticles Enhance the Intracellular Uptake and Antibacterial Activity of Rifampicin. ACS applied materials & interfaces 12 (7) (2020)
Tahnee J Dening, Nicky Thomas, Shasha Rao, Cis van Looveren, Filip Cuyckens, René Holm, Clive A Prestidge
Montmorillonite and Laponite Clay Materials for the Solidification of Lipid-Based Formulations for the Basic Drug Blonanserin: In Vitro and in Vivo Investigations. Molecular pharmaceutics 15 (9) (2018)
Hayley B Schultz, Miia Kovalainen, Karl F Peressin, Nicky Thomas, Clive A Prestidge
Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance. The Journal of pharmacology and experimental therapeutics 370 (3) (2018)
Katharina Richter, Nicky Thomas, Jolien Claeys, Jonathan McGuane, Clive A Prestidge, Tom Coenye, Peter-John Wormald, Sarah Vreugde
A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity. Antimicrobial agents and chemotherapy 61 (6) (2017)

Nicky Thomas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicky Thomas